Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 3/7 cls
Biogen Idec Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Upgrade Outperform (from market perform) -4% $328.75
Birchenough also raised his target to $422 from $286 after his pipeline review revealed $1B-plus prospects for Alprolix

Read the full 612 word article

How to gain access

Continue reading with a
two-week free trial.